Stocks Health care NATR
NASDAQ · Health careNatures Sunshine Products Inc (NATR)
Natures Sunshine Products Inc brought in $492M of revenue over the twelve months to June 30, 2026, up 6.8% from a year earlier. Net income was $18.1M, a net margin of 3.7%. Operating cash flow minus capital spending left $28.8M of free cash flow in fiscal 2025. At June 30, 2026 it held $82.5M in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 6, 2026.
What Natures Sunshine Products Inc does
Natures Sunshine Products Inc is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on NASDAQ under the ticker NATR.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | $480.1M | $19.5M | $1.06 | $28.8M |
| 2024 | $454.4M | $7.7M | $0.40 | $14.3M |
| 2023 | $445.3M | $15.1M | $0.77 | $30.7M |
| 2022 | $421.9M | -$390K | -$0.02 | -$6.9M |
| 2021 | $444.1M | $28.9M | $1.42 | $27.9M |
| 2020 | $385.2M | $21.3M | $1.07 | $32.8M |
Where NATR ranks in Health care
Dividends
| Fiscal year | Per share | Paid out | Of profit |
|---|---|---|---|
| 2022 | $0.00 | $0 | n/a |
| 2021 | $1.00 | $19.9M | 69% |
| 2020 | $0.00 | $0 | 0% |
| 2019 | $0.00 | n/a | n/a |
| 2018 | $0.00 | $0 | n/a |
| 2017 | $0.10 | $1.8M | n/a |
Latest SEC filings
What Natures Sunshine Products Inc has filed recently, newest first. Each links to the original document on SEC EDGAR.
- August 10, 2026Passive stake changed SCHEDULE 13G/A
- August 6, 2026Quarterly report 10-Q · period to June 30, 2026
- August 6, 2026
- May 15, 2026
- May 11, 2026
- May 7, 2026
- May 7, 2026Quarterly report 10-Q · period to March 31, 2026
- April 20, 2026Additional proxy material DEFA14A
- March 27, 2026Additional proxy material DEFA14A
- March 27, 2026Proxy statement DEF 14A
What is NATR worth? A DCF from its reported cash flow
Insider trades
What the people running Natures Sunshine Products Inc did with its shares, from the Form 4 filings they must send the SEC within two business days.
No insider bought or sold shares on the open market in the last 90 days. The 3 reported changes were pay in shares, option exercises, shares withheld for tax or gifts.
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| September 2, 2026 | Perkins Ruth AnnEVP, Chief Financial Officer | Received as pay | 39,384 | - |
| September 2, 2026 | Perkins Ruth AnnEVP, Chief Financial Officer | Received as pay | 36,049 | - |
| September 1, 2026 | Lanoy Jonathan DavidSVP, Chief Accounting Officer | Received as pay | 7,210 | - |
Questions about NATR
What does Natures Sunshine Products Inc do?
Natures Sunshine Products Inc is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on NASDAQ under the ticker NATR.
Is Natures Sunshine Products Inc profitable?
Yes. Over the twelve months to June 30, 2026 it reported net income of $18.1M on revenue of $492M, a net margin of 3.7%.
How much revenue does Natures Sunshine Products Inc make?
Over the twelve months to June 30, 2026 Natures Sunshine Products Inc reported revenue of $492M. That is 6.8% more than a year earlier.
When did Natures Sunshine Products Inc last report?
Its most recent periodic report is the quarterly report (10-Q) filed on August 6, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the insider trade from September 15, 2026.
Similar companies
Compare NATR with
Follow NATR
Get an email when Natures Sunshine Products Inc files with the SEC: results, executive changes, material agreements and annual reports.
Follow NATR: get an email when it filesWhere the numbers come from
Financial figures are the values Natures Sunshine Products Inc tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.